Study of HL-085 and Vemurafinib in Metastatic Colorectal Cancer (mCRC)
Clinical trial NCT05233332 · UNKNOWN
Trial details
- NCT number
- NCT05233332
- Sponsor
- Shanghai Kechow Pharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2024-01-20
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.